LUNAC

Unknown (Unknown)

Start Date End Date Funded Value Relevance

CSV

25 50 100

£249,917

Jun 20 - Nov 20

Continuity Award of Development of First-in class small molecule preclinical candidate anticoagulant targeting activated factor XII with minimal risk of bleeding -105439

Innovate UK award to LUNAC and Helen Philippou

£3,142,247

Sep 19 - May 21

Development of First-In Class Small Molecule Preclinical Candidate Anticoagulant Targeting Activated Factor XII with Minimal Risk of Bleeding

Innovate UK award to LUNAC and Helen Philippou

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}